American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Tallman
    Tallman
  5. Perales
    Perales
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Kernan
    Kernan
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (3844)
  2. Hematologic Malignancies, Division of (3639)
  3. Center for Hematologic Malignancies (3542)
  4. GSK Faculty (1553)
  5. Adult Leukemia (1289)
  6. Sloan Kettering Institute Faculty (1065)
  7. Bone Marrow Transplant (936)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (931)
  9. Lymphoma (898)
  10. Tow Center for Developmental Oncology (TCDO) (863)
Search Within
Formats
  1. Meeting Abstract (3939)
  2. Journal Article (1239)
  3. Research Letter (44)
  4. Review (44)
  5. Editorial (34)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3844)
  2. Hematologic Malignancies, Division of (3639)
  3. Center for Hematologic Malignancies (3542)
  4. GSK Faculty (1553)
  5. Adult Leukemia (1289)
  6. Sloan Kettering Institute Faculty (1065)

More Groups

People
  1. Sergio Giralt (337)
  2. Andrew Zelenetz (328)
  3. Ross Levine (312)
  4. Martin Tallman (298)
  5. Miguel-Angel Perales (292)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (43)
  2. 2024 (217)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (4951)
  2. Blood Advances (322)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5323)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Diagnostic utility of the (18)f-FDG PET/CT scan in solid organ transplant patients with EBV reactivation at risk for post-transplant lymphoproliferative disorder
    Meeting Abstract

    Cherng, H. J. J.; Scalabrino, R.; Gould, P.; Sanjurjo, A.; Cuzzo, B.; Jain, S.; Ma, H. Y.; Ford, M.; Orlando, E. H.; De Jong, D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Radiation therapy for Burkitt lymphoma: Multi-decade insights from a single center
    Meeting Abstract

    Tward, A.; Patel, R. R.; Isgor, I.; Galera, P.; Lopez, K.; Fregonese, B.; Moore, Z.; Wolden, S.; Yahalom, J.; Imber, B. S.
    Blood (2024)

    Fulltext@MSK | Save
  • 5-year follow-up of the phase 2 optic study in patients with chronic-phase chronic myeloid leukemia: Efficacy, safety, and first end-of-treatment mutational results
    Meeting Abstract

    Cortes, J. E.; Deininger, M. W.; Apperley, J.; Arthur, C. K.; Chuah, C.; Hochhaus, A.; de Lavallade, H.; Lipton, J. H.; Lomaia, E.; McCloskey, J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Updated results from the phase 3 MANIFEST-2 study of pelabresib in combination with ruxolitinib for Janus kinase inhibitor-naive patients with myelofibrosis
    Meeting Abstract

    Mascarenhas, J. O.; Grosicki, S.; Chraniuk, D.; Abruzzese, E.; Bose, P.; Gerds, A. T.; Vannucchi, A. M.; Palandri, F.; Lee, S. E.; Gupta, V.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Patients with AML and an IDH2-R172 mutation exhibit a unique response to intensive induction chemotherapy, suggesting futility of mid-cycle bone marrow biopsy and caution when considering re-induction
    Meeting Abstract

    Yisraeli Salman, M.; Terry, A. R.; Derkach, A.; Nemirovsky, D.; Chin, K. K.; Valtis, Y. K.; Boussi, L.; Spivey, T.; Xiao, W.; Famulare, C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Final response and survival results from a phase II trial of pembrolizumab and entinostat in relapsed/refractory Hodgkin lymphoma
    Meeting Abstract

    Stuver, R.; Vardhana, S. A.; Ganesan, N.; Boardman, A. P.; Caron, P.; Chang, T.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Duvelisib in patients with relapsed/refractory peripheral T-cell lymphoma: Final results from the phase 2 PRIMO trial
    Meeting Abstract

    Mehta-Shah, N.; Zinzani, P. L.; Jacobsen, E. D.; Zain, J.; Mead, M.; Casulo, C.; Gritti, G.; Pinter-Brown, L. C.; Izutsu, K.; Bentur, O. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Pembrolizumab for front-line treatment of extranodal NK/T-cell lymphoma
    Meeting Abstract

    Moskowitz, A.; Advani, R. H.; Ganesan, N.; Chang, T.; Hancock, H.; Davey, T.; Miller, T.; Gibaldi, A.; Smith, M.; Assini, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Codon-specific differences in RAS mutations in AML and differential response to therapeutic agents
    Meeting Abstract

    Anandappa, A. J.; Trivedi, V.; Merlinsky, T.; Delgaudio, N.; Guzzardi, E.; Wooten, A.; Starczynowski, D.; Bowman, R. L.; Levine, R.; Miles, L. A.
    Blood (2024)

    Fulltext@MSK | Save
  • Efficacy of a novel BCL-XL degrader, DT2216, in preclinical models of post-myeloproliferative neoplasm secondary AML
    Meeting Abstract

    Wang, Z.; Skwarska, A.; Poigailwar, G.; Chaudhry, S.; Rodriguez-Meira, A.; Sui, P.; Olivier, E.; Jia, Y.; Ramage, C. L.; Zheng, G.; more...
    Blood (2024)

    Fulltext@MSK | Save